You are here: Industry Insights > oncology

News List

Oncologist Herbert Loong Joins George Clinical Scientific Leadership prnasia
January 19, 2021
Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, S.A.R., China, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical resea
BrickBio Inks ADC Co-Development Deal contractpharma
January 07, 2021
BrickBio, a company specializing in site-specific bioconjugation for improved therapeutics, has signed an agreement with a large pharmaceutical company to co-develop a therapeutic antibody drug conjugate (ADC).
Servier to Acquire Agios Pharmaceuticals' Oncology Business prnasia
December 22, 2020
Servier, a global pharmaceutical company, announced that it has entered into an agreement for the acquisition of Agios Pharmaceuticals' oncology business including its commercial, clinical and research-stage oncology portfolio for up to $2 billion ...
Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration prnasia
December 15, 2020
3SBio Inc.'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. and Verseau Therapeutics, Inc. announced the selection of a monoclonal antibody targeting VSIG4, as a licensed program under their partnership agreement focused on the ...
I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board prnasia
December 02, 2020
I-Mab announced the strengthening of its Scientific Advisory Board with the appointment of leading international experts Dr. Chen Dong and Dr. Jun Ma.
China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth: GlobalData expresspharma
December 01, 2020
Between 2017 and 2019, the number of clinical trials initiated for PD-1/PD-L1 targeted combination therapies increased substantially, which continued in 2020, albeit with a significantly slower rate possibly due to the global COVID-19 pandemic.
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX prnasia
November 20, 2020
Qiming's portfolio company Antengene officially listed on the Main Board of The Stock Exchange of Hong Kong, S.A.R., China Limited today.
Merck to acquire oncology firm VelosBio for $2.75bn pharmaceutical-technology
November 09, 2020
Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of Pappas Capital’s portfolio company VelosBio through a subsidiary for $2.75bn in cash, subject to certain customary adjustments.
Oncology development programme launches at UK life science campus pharmatimes
November 06, 2020
A new national oncology development programme is being launched by Bruntwood SciTech at Alderley Park, the UK’s largest single site life science campus.
Crown Biosciences Opens Facility in China contractpharma
November 06, 2020
Crown Bioscience, a JSR Life Sciences company, has opened a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page